Ki-Hyeok Kwon1, Catherine M Serrano1, Michael Koch2, Louis R Barrows2, Ryan E Looper1. 1. †Department of Chemistry, University of Utah, 315 South 1400 East, Salt Lake City, Utah 84112, United States. 2. ‡Department of Pharmacy/Toxicology, University of Utah, 30 South 2000 East, Salt Lake City, Utah 84112 United States.
Abstract
A cascade silver(I)-catalyzed hydroamination/Michael addition sequence has been developed to deliver highly substituted bicyclic guanidines. This transformation gives rise to geometrically and constitutionally stable ene-guanidines and generates a remote stereocenter with moderate to high diastereoselectivity.
A cascade silver(I)-catalyzed hydroamination/Michael addition sequence has been developed to deliver highly substituted bicyclic guanidines. This transformation gives rise to geometrically and constitutionally stable ene-guanidines and generates a remote stereocenter with moderate to high diastereoselectivity.
Polycyclic guanidinium ion natural
products exhibit a broad spectrum of biological activity and embed
an important structural unit that is critical for medicinal chemistry
and for broader discovery-based applications.[1] Unnatural polycyclic guanidines have also been employed as competent
organocatalysts with unique coordination arrangements and an array
of donor/acceptors.[2,3] Given their broad utility, a variety
of synthetic methods have been developed to access this class of compounds.
Some of these methods include the cyclization of propargylguanidines,[4] intermolecular diamination of alkenes,[5] reaction of unsaturated molecules with aziridines
and diazirenes,[6] intramolecular alkylation
of guanidines,[7] and radical cascade cyclizations,[8] among others.[9] Very
recently, titanium amides have been shown to catalyze the synthesis
of cyclic guanidines from diamines and carbodiimides in a single step.[10] Unfortunately, most of these synthetic routes
require multistep synthesis or preparation of highly functionalized
precursors. The development of advanced, efficient, and facile methods
to access these compounds thus remains an important goal for synthetic
chemists.[11] Herein, we report a one-step
Ag(I)-catalyzed hydroamination/Michael addition sequence of mono-N-acryloylpropargylguanidines yielding bicyclic guanidines
with complete regiocontrol and modest to high levels of 1,5-asymmetric
induction.The synthesis of unsymmetrical guanidines has been
intensively
investigated, and a variety of guanylating agents are available.[12] We recently reported the chlorotrimethylsilane activation of acylcyanamides
as an efficient method for the synthesis of mono-N-acylguanidines via a reactive N-silylcarbodiimide
intermediate.[14]This discovery prompted
us to consider new types of guanylating
agents, capable of engaging cascade reactivity which could lead to
the formation of bicyclic guanidines. We became interested in the
unsaturated N-cyanoacylamide 1 as a
guanylating agent and precursor for bicyclic guanidines (Scheme 1). Upon reaction with TMSCl, N-cyanoacylamide 1 should generate an N-silylcarbodiimide
intermediate capable of reaction with a propargylamine 2. Acryloylguanidines (e.g., 3) themselves do not undergo
intramolecular cyclization due to internal hydrogen bonding by the
NH2 group to the carbonyl, locking it in an unproductive s-cis conformer. We envisioned that initial 5-exo selective cyclization of the guanidine on a tethered alkyne would
generate an intermediate that can undergo rapid s-cis → s-trans isomerization by the introduction
of significant pseudo-A1,3 strain. This would then allow
the formation of the 6-membered ring via Michael addition with the
unsubstituted guanidinenitrogen (N2) (Scheme 1). If successful, this would provide access to highly
substituted 5,6-membered bicyclic guanidines.
Scheme 1
Synthetic Strategy
for the Bicyclic Guanidines
To execute this strategy, we first examined the direct
activation
of the N-cyanoacrylamides 1a–h and their reaction with propargylamine 2a (Table 1). The reaction of both 1a and 1b with 2a yielded products 3a/b in moderate yields (entries 1 and 2). The reaction of more electron-deficient
cinnamoyl derivatives (1c–e) with 2a gave better yields of propargylguanidines 3c–e (entries 3–5). Conversely, the more
electron-rich N-cyanoacrylamide (1f)
gave its corresponding propargylguanidine in attenuated yield (entry
6). The reactivity of these intermediate N-silylcarbodiimides
appears to be acutely sensitive to the electronic nature of the N-cyanoacrylamides. For example, the more electron-rich
substrates 1g/h, which are β-disubstituted, fail
to react with 2a (entries 7 and 8).
Table 1
Survey of Guanylation Activity with N-Cyanoacrylamidesa
Reaction conditions: cyanamide (1.0
mmol), amine (1.0 mmol), TMSCl (1.2 equiv), NEt3 (1.5 equiv),
CH2Cl2 (10 mL), 8 h.Isolated yield. TMSCl = chlorotrimethylsilane,
NEt3 = triethylamine.Having synthesized the required substrates, we next investigated
the cascade cyclization–Michael addition sequence. Indeed,
Ag(I) initiated a highly selective 5-exo cyclization
guanidine as previously reported.[5a−5c] Accordingly, treatment
of 3a in the presence of AgNO3 (10 mol %)
in acetonitrile at room temperature provided 4a in good
chemical yield as a mixture of two diastereoisomers that were readily
separable by chromatography (78% yield, dr = 2:1) (Scheme 2). It is important to note that the initial hydroamination
proceeds with excellent regiochemical control via attack by the imino-nitrogen
(N3), as drawn. After the stereochemistry of syn-4a and anti-4a was confirmed
by X-ray crystallography, it became straightforward to identify the
relative configurations of these products by the larger diaxial 3J coupling between H4 and the
neighboring methylene group in the anti-diastereomer.
As expected from an anti-aminometalation pathway,
the products are formed as single geometric isomers the C–C
double bond. The fact that this transformation proceeded with modest
diastereoselectivity was surprising, given that the two stereocenters
are five atoms apart and separated by an almost planar 5,6-fused heterocyclic
system. When the crystal structures of syn/anti-4a were evaluated, it was noted that the anti-diastereomer had considerable torsional strain about
the C2–C3 bond. The alkene is bent significantly
out of the plane with N3, deconjugating the alkene from
the guanidine, allowing us to intuitively assign the syn-diastereomer as the thermodynamically favored product. Prior to
the Michael addition, torsional strain between R3–R4–R5 might preferentially position the Michael
acceptor above or below the plane of the cyclic guanidine depending
on the relative torsion this interaction imparted to the N3–carbonyl bond. Examples of Ag(I)-catalyzed Michael additions
of amines are rare,[15] and we were doubtful
that catalysis of this step would significantly impact the reaction
outcome. Probing these torsional effects on the reaction outcome guided
our substrate analysis.
Scheme 2
Synthesis of Bicyclic Guanidines from Propargylguanidines
and Confirmation
of Their Stereochemistry by X-ray Crystallography
We first examined substrates where R4 = aryl, anticipated
to behave as a large substituent (Figure 1).
All substrates in this series were tolerated, giving the products
in good chemical yield and similar diastereoselectivities. Examples 4b–d demonstrate that a variety of electron-withdrawing
and -donating groups on the acryloylguanidine are tolerated to give
the products in good chemical yield and similar diastereoselectivities.
Substitution of the alkyne substituent (R5) to a smaller
alkyl group also had no effect on diastereoselectivity (4e). Introduction of a larger o-substituted aryl group
(4f) or a larger group at N1 was also inconsequential
(4g–i). Unexpectedly, we found that
the 2-naphthyl-substituted acryloylguanidines cyclized with enhanced
diastereoselectivity 10:1 dr for 4j and 5:1 dr for 4k. While independently the interaction R3–R4–R5 is critical for selectivity, the interactions
do appear to be additive. For example, a large substituent at N1 and C3 (e.g., m-(trifluoromethyl)phenyl)
improves the selectivity to 10:1 dr (4l). Inclusion of
the 2-naphthyl group enhances the diastereoselectivity of the product 4m to >20:1 by 1H NMR.
Figure 1
Substrate scope for the
cyclization/Michael addition catalyzed
by AgNO3 where R4 = aryl. Reaction conditions:
substrate (0.3 mmol), AgNO3 (10 mol %), MeCN (0.1 M), 8
h. The diasteromeric ratios were determined by 1H NMR analysis
of the crude mixture.
Substrate scope for the
cyclization/Michael addition catalyzed
by AgNO3 where R4 = aryl. Reaction conditions:
substrate (0.3 mmol), AgNO3 (10 mol %), MeCN (0.1 M), 8
h. The diasteromeric ratios were determined by 1H NMR analysis
of the crude mixture.We next examined substrates where R4 = alkyl or
α-branched,
anticipated to behave as a small group by virtue of their ability
to orient a methynehydrogen toward the alkene (Figure 2). Quite to our surprise, all of these substrates cyclized
with higher diastereoselectivity but favored the anti-diastereomer. The substrates where R4 = benzyl or isopropyl
gave anti-5a and anti-5b in good diastereoselectivity (10:1 dr or >20:1
dr,
respectively). Deletion of a substituent on the alkyne did lower the
diastereoselectivity to 4:1 dr as seen with 5c. Other
substituent interchanges still delivered the products (5d–i) with good levels of anti-diastereoselectivity ranging from 5:1 to >20:1 dr.
Figure 2
Substrate scope
for the cyclization/Michael addition catalyzed
by AgNO3 where R4 = alkyl. Reaction conditions:
substrate (0.3 mmol), AgNO3 (10 mol %), MeCN (0.1 M), 8
h. The diastereomeric ratios were determined by 1H NMR
analysis of the crude mixture.
Substrate scope
for the cyclization/Michael addition catalyzed
by AgNO3 where R4 = alkyl. Reaction conditions:
substrate (0.3 mmol), AgNO3 (10 mol %), MeCN (0.1 M), 8
h. The diastereomeric ratios were determined by 1H NMR
analysis of the crude mixture.In the context of delivering a small collection of this new
scaffold
for initial biological evaluation, we also examined this cascade reaction
on substrates lacking a substituent at R4 (Figure 3). A variety of substituents on the N1 guanidinenitrogen were well tolerated, generating the corresponding
bicyclic products in good chemical yield (6a–i). More electron-rich alkyne substituents were also tolerated
(6e). All of the Michael acceptors examined were also
tolerated (6f–i). Notably, this synthetic
procedure is scalable and practical providing 6d in 67%
yield when performed on a 2.5 mmol scale.
Figure 3
Substrate scope for the
cyclization/Michael addition catalyzed
by AgNO3 where R4 = H. Reaction conditions:
substrate (0.3 mmol), AgNO3 (10 mol %), MeCN (0.1 M), 8
h. The diastereomeric ratios were determined by 1H NMR
analysis of the crude mixture. b Performed on a 2.5 mmol
scale.
Substrate scope for the
cyclization/Michael addition catalyzed
by AgNO3 where R4 = H. Reaction conditions:
substrate (0.3 mmol), AgNO3 (10 mol %), MeCN (0.1 M), 8
h. The diastereomeric ratios were determined by 1H NMR
analysis of the crude mixture. b Performed on a 2.5 mmol
scale.These architectures comprise other
functional groups that can be
engaged. For example, reduction of the ene–guanidine in 6d cleanly provides the saturated tetrahydroimidazolpyrimidone 7 (Scheme 3a). Attempts to isomerize
the alkene and generate the dihydroimidazolpyrimidone under acidic
conditions were unsuccessful. Exposure of 6d to 1:1 CH2Cl2:TFA returned the starting material with the
alkene both constitutionally and geometrically intact. We did, however,
observe that the alkene could be isomerized under hydrogenolysis conditions.
In the presence of a nucleophilic solvent, the ring-opened methyl
ester 8 can be obtained, representing an interesting
entry to N-imidazolyl-β-amino ester (Scheme 3b). Interestingly, attempts to isomerize the alkene
in anti-5f with HCl/Et2O/MeOH
did not affect the alkene (Scheme 3c). Instead,
epimerization occurred at C4, as evidenced by the smaller
diaxial 3J coupling to H4,
suggesting that the Michael addition is reversible under acidic conditions
and that the syn-diastereomer is indeed thermodynamically
preferred. It should be noted that resubjection of the isolated diastereomers
or mixtures thereof to the original Ag-catalyzed reaction conditions
does not change the product ratio, suggesting that the initial product
ratio is kinetic.
Scheme 3
Transformation of the Resultant Bicyclic Guanidines
An initial evaluation of the
biological activities of these intriguing
scaffolds identified several members to be inhibitory toward the growth
of an attenuated strain of Mycobacterium tuberculosis H37Ra. For example, compound 6d inhibited growth with
an IC50 = 7.7 μM and showed only moderate cytotoxicity
against humanCEM-TART T-cells[16] (IC50 = 53.0 μM).[17] The syn-diastereomer of compound syn-4d was also active with an IC50 = 8.6 μM
but was slightly more cytotoxic toward T-cells (IC50 =
32.1 μM). Interestingly, the diastereomeric compound, anti-4d, showed no activity suggesting a specific
molecular interaction might be responsible for its activity. Compound 4d was active against a broader range of organisms including
Gram-negative bacteria (Escherichia coli; MIC100 = 25.0 μM and Acinetobacter baumanii; MIC100 = 12.5 μM) as well as the Gram-positive
bacterium Bacillus subtilus (MIC100 =
6.25 μM) and opportunistic fungi Candida albicans (MIC100 = 12.5 μM). Current studies are aimed at
penetrating the mechanism of action of these new bicyclic guanidines
antimicrobial agents.In summary, we have developed a method
for the synthesis of highly
substituted bicyclic guanidines in good to excellent yields from readily
accessible propargylguanidines. This cascade hydroamination–Michael
addition sequence gives rise to products as a single regioisomer and
with a constitutionally and geometrically stable ene–guanidine
functional group. Substituent variations can deliver products with
high diastereoselectivity despite the newly formed stereocenter being
five atoms removed and spanned by an almost planar heterocyclic core.
These interesting scaffolds have already garnered our interest as
antitubercular agents. The modularity of this approach should expedite
follow-up investigations to identify candidates with increased potency
and selectivity against M. tuberculosis.